Vimarsana
Biggest News Aggregation in the World

Page 2 - Study Number News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Number Today - Breaking & Trending Today

NIMH » Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers - Vimarsana News

NIMH » Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers

Join a Research Study: Enrolling locally from the Washington, D.C. metro region To find out if you qualify, 1-301-435-4516 [TTY: 1-866-411-1010]. The purpose of this study is to understand brain development during childhood and brain changes with aging. We will look at brain changes and development in healthy adults and children. We will also look at brain changes and development in people with different developmental disorders, including sex chromosome variations. Previous studies have shown that parts of the brain develop at different times. They have also shown that brain development can ...

Source: nih.gov
NIMH » Adults: Healthy Volunteers - Vimarsana News

NIMH » Adults: Healthy Volunteers

Researchers are enrolling healthy volunteers for an outpatient research study to learn more about how the brain works. Research participation may include cognitive tasks, personality tests, brain imaging and/or magnetoencephalography (MEG).  Participants may choose which research tasks they would like to participate in, which determines the number of visits (1-12) to the NIH Clinical Center in Bethesda, MD. The study is enrolling eligible participants, between the ages of 18 and 65, who are in good physical health, and at least a high school education. There is no cost to participate and com...

Source: nih.gov
NIMH » Healthy Volunteers to Assist in finding causes of depression in teenagers - Vimarsana News

NIMH » Healthy Volunteers to Assist in finding causes of depression in teenagers

Join a Research Study: Enrolling nationally from around the country To find out if you qualify, 1-301-827-1350 [TTY: 1-866-411-1010]. Healthy volunteers (teens who do not have mental health diagnoses) are needed to assist investigators find causes of depression in teenagers. The study goals are to understand how the brain changes when teenagers have depression and use that knowledge to find better treatments for depression. Healthy volunteers who participate in research assist investigators by being members of a group that can be compared to a group of those who have major depression. The st...

Source: nih.gov
NIMH » Adults: Depression - Vimarsana News

NIMH » Adults: Depression

The purpose of this study is to evaluate the rapid and sustained antidepressant effects of repeated doses of ketamine in the brain. We want to learn how ketamine affects areas of the brain important in regulating mood and if there are unique signatures that could help predict who may respond to the drug. Also, we want to see if repeated doses of ketamine are safe and effective in treating the symptoms of depression. We are enrolling eligible adults, ages 18 to 65 with major depressive disorder. This inpatient study lasts 14-20 weeks and procedures include a medication taper and drug-free peri...

Source: nih.gov
Nanobiotix Announces Key Development Milestones for 2021 After Successful Nasdaq Initial Public Offering - Vimarsana News

Nanobiotix Announces Key Development Milestones for 2021 After Successful Nasdaq Initial Public Offering

Nanobiotix Announces Key Development Milestones for 2021 After Successful Nasdaq Initial Public Offering Nanobiotix will use a portion of the proceeds from the its IPO to launch its global phase III registration study in head and neck cancer in the United States in 2021 Following previously reported preliminary data regarding the ability of NBTXR3 to help transform anti-PD-1 non-responders into responders, the Company will provide the next update on its immuno-oncology phase I basket study evaluating NBTXR3 in combination with anti-PD-1 checkpoint inhibitors in the second quarter of 2021 The ...